Yewei Jia
Shaoxing, 312000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Morusin Inhibits RANKL-induced Osteoclastogenesis and Ovariectomized Osteoporosis.
Journal: Combinatorial chemistry & high throughput screening
Published: March 09, 2023
Galangin attenuates IL-1β-induced catabolism in mouse chondrocytes and ameliorates murine osteoarthritis.
Journal: American journal of translational research
Published: December 22, 2020
Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo.
Journal: Drug design, development and therapy
Published: August 01, 2020
Correction to: Garcinol Suppresses IL-1β-Induced Chondrocyte Inflammation and Osteoarthritis via Inhibition of the NF-κB Signaling Pathway.
Journal: Inflammation
Published: June 17, 2020
Byakangelicin inhibits IL-1β-induced mouse chondrocyte inflammation in vitro and ameliorates murine osteoarthritis in vivo.
Journal: International immunopharmacology
Published: February 06, 2020
Morusin Ameliorates IL-1β-Induced Chondrocyte Inflammation and Osteoarthritis via NF-κB Signal Pathway.
Journal: Drug design, development and therapy
Published: January 01, 2020
Disulfiram suppressed ethanol promoted RANKL-induced osteoclastogenesis in vitro and ethanol-induced osteoporosis in vivo via ALDH1A1-NFATc1 axis.
Journal: Aging
Published: July 29, 2019
TAZ inhibits osteoclastogenesis by attenuating TAK1/NF-κB signaling.
Journal: Bone research
Published: May 21, 2019
Vitexin suppresses RANKL-induced osteoclastogenesis and prevents lipopolysaccharide (LPS)-induced osteolysis.
Journal: Journal of cellular physiology
Published: November 13, 2018
Garcinol suppresses RANKL-induced osteoclastogenesis and its underlying mechanism.
Journal: Journal of cellular physiology
Published: June 19, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026